within Pharmacolibrary.Drugs.ATC.S;

model S01AB04
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.1666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AB04</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sulfacetamide is a sulfonamide antibiotic approved for topical treatment of bacterial infections, particularly in ophthalmology for conjunctivitis and other eye infections. It is available as eye drops, ointments, and, less commonly, as oral formulations. Sulfacetamide is generally not used systemically nowadays because of the risk of side effects and the availability of better alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for topical (ophthalmic) administration, as no systemic kinetic studies with specific values exist; limited absorption is expected through ocular tissues; no well-established compartmental PK available for topical use in humans.</p><h4>References</h4><ol><li><p>Johansen, S, et al., &amp; Prause, JU (1996). An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension. <i>Acta ophthalmologica Scandinavica</i> 74(3) 259–264. DOI:<a href=\"https://doi.org/10.1111/j.1600-0420.1996.tb00088.x\">10.1111/j.1600-0420.1996.tb00088.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8828723/\">https://pubmed.ncbi.nlm.nih.gov/8828723</a></p></li><li><p>Johansen, S, et al., &amp; Prause, JU (1996). A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension. <i>Acta ophthalmologica Scandinavica</i> 74(3) 253–258. DOI:<a href=\"https://doi.org/10.1111/j.1600-0420.1996.tb00087.x\">10.1111/j.1600-0420.1996.tb00087.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8828722/\">https://pubmed.ncbi.nlm.nih.gov/8828722</a></p></li><li><p>Scruggs, J, et al., &amp; Hanna, C (1978). Route of absorption of drug and ointment after application to the eye. <i>Annals of ophthalmology</i> 10(3) 267–271. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/655537/\">https://pubmed.ncbi.nlm.nih.gov/655537</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AB04;
